Estherline Thoby | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Estherline J. Thoby
Rutgers Robert Wood Johnson Medical School, United States

Estherline Thoby
Affiliation Rutgers Robert Wood Johnson Medical School
Country United States
Scopus ID 57201254799
Documents 4
Citations 26
h-index 2
Subject area Medicine and Health Sciences
Event Global Innovation Technologist Awards

The Innovative Research Award profile presents Estherline Thoby’s documented scholarly activity in medicine and health sciences, with particular attention to pediatric practice and neonatal hyperbilirubinemia. Her listed publication, “Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines,” addresses clinical practice in the context of updated guidance for neonatal jaundice. The profile summarizes the supplied bibliometric information and identifies the research themes relevant to academic recognition. The available information does not establish an award decision or independent assessment outcome.

Abstract

Estherline J. Thoby is associated with research in pediatric medicine and neonatal hyperbilirubinemia. Her listed 2026 publication examines pediatricians’ practice patterns concerning the revised 2022 neonatal hyperbilirubinemia guidelines. This topic is relevant to understanding how clinical recommendations are interpreted and applied in pediatric settings. The supplied Scopus profile reports four documents, 26 citations and an h-index of 2. These figures provide a limited bibliometric snapshot rather than a complete evaluation of clinical relevance, methodological quality or research contribution. [1]

Keywords

Estherline Thoby; neonatal hyperbilirubinemia; pediatric practice; clinical guidelines; neonatal jaundice; evidence-based medicine; pediatricians; medicine and health sciences; research impact.

Introduction

Neonatal hyperbilirubinemia is a common clinical concern involving elevated bilirubin levels in newborns. Clinical guidelines support decisions about risk assessment, monitoring and treatment. Examining pediatricians’ practice patterns can help describe the relationship between published recommendations and real-world clinical approaches. The 2022 revised guidance provides the context for the publication attributed to Thoby and co-authors. The available citation information identifies a relevant research topic, but detailed findings should be drawn from the full article rather than inferred from its title. [2]

Research Profile

The supplied institutional affiliation is Rutgers Robert Wood Johnson Medical School in the United States. The profile identifies medicine and health sciences as the subject area. The reported bibliometric indicators are four documents, 26 citations and an h-index of 2. These metrics describe indexed scholarly output and citation activity as supplied; they may change as databases are updated. The information provided does not independently verify employment dates, authorship contributions or the completeness of the publication record.

Research Contributions

The identified research topic concerns the implementation of revised neonatal hyperbilirubinemia guidance in pediatric practice. Research on practice patterns can help characterize clinicians’ familiarity with recommendations and identify areas for further education or investigation. However, specific conclusions about adherence, treatment choices or patient outcomes cannot be established from the citation metadata alone. Assessment of these contributions requires the full publication, including its methods, results and limitations.

Publications

The supplied publication record is:

  • Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Authors listed: E. J. Thoby, A. A. Lariviere, K. A. Briski and A. Petrova. Pediatric Reports, 2026. The supplied record reports zero citations for this individual article at the time of the provided snapshot.

A DOI and direct full-text URL were not supplied and are therefore not asserted here. The publication title and author details should be checked against the journal’s official record before formal bibliographic reuse.

Research Impact

The supplied Scopus figures indicate a modest indexed publication record with measurable citation activity. Citation counts and h-index can support comparisons when interpreted alongside career stage, specialty, authorship role and publication context. They do not independently measure clinical influence, originality or patient benefit. Because the identified 2026 article is reported with zero citations, its potential influence should be assessed over time and through substantive review of its findings.

Award Suitability

The Innovative Research Award profile for the Global Innovation Technologist Awards provides a framework for presenting the researcher’s subject area, publication activity and research interests. Relevant considerations for a formal award evaluation include:

  • Relevance and originality of the research question.
  • Methodological quality and transparency of reported findings.
  • Potential contribution to pediatric practice and evidence-based care.
  • Verified publication records and independently documented research outcomes.

These considerations are evaluation criteria, not confirmation that an award has been granted. A final determination requires the event’s official assessment process and supporting evidence.

Conclusion

Estherline Thoby’s listed work addresses a clinically relevant topic in neonatal and pediatric medicine. The available profile provides basic bibliometric information and a 2026 publication reference, while leaving the article’s detailed findings and broader clinical implications to be verified from primary sources. This page serves as a neutral academic recognition profile, not an independent validation of research quality or an announcement of award selection.

References

  1. Elsevier. (n.d.). Scopus author details: Author ID 57201254799. Scopus. Bibliometric figures reproduced from the information supplied for this profile.
    https://www.scopus.com/authid/detail.uri?authorId=57201254799
  2. Thoby, E. J., Lariviere, A. A., Briski, K. A., & Petrova, A. (2026). Pediatricians’ Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines. Pediatric Reports. Publication details are transcribed from the supplied citation; volume, issue, page range and DOI were not provided.
  3. Kemper, A. R., Newman, T. B., Slaughter, J. L., et al. (2022). Clinical practice guideline revision: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 150(3), e2022058859.
    https://doi.org/10.1542/peds.2022-058859
  4. World Health Organization. (n.d.). Newborn health. World Health Organization. General reference for newborn health context.
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Dominic Richmond | Health Professions | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Dominic Richmond
University of Birmingham, United Kingdom
Dominic Richmond
Affiliation University of Birmingham
Country United Kingdom
Scopus ID 57189870953
Documents 2
Citations 32
h-index 2
Subject Area Health Professions
Event Global Innovation Technologist Awards
ORCID 0009-0001-9270-937X

Dominic Richmond is a United Kingdom-based physiotherapy researcher and advanced clinical practitioner associated with the University of Birmingham and Cambridge University Hospitals NHS Foundation Trust. His academic and clinical work focuses on musculoskeletal rehabilitation, anterior cruciate ligament (ACL) injury management, sports physiotherapy, and evidence-based rehabilitation practices. Richmond has contributed to clinical research addressing return-to-sport outcomes and musculoskeletal injury prevention within elite athletic and healthcare environments.[1] His profile reflects a combination of academic achievement, clinical leadership, and interdisciplinary healthcare research aligned with contemporary health professions scholarship.[2]

Abstract

This article presents an academic overview of Dominic Richmond, a physiotherapist and healthcare researcher whose work has contributed to sports medicine, musculoskeletal rehabilitation, and anterior cruciate ligament research. Richmond’s clinical and academic activities integrate evidence-based rehabilitation methods with applied healthcare delivery in hospital and elite sporting environments. His published work and conference contributions demonstrate continuing engagement with ACL rehabilitation pathways, return-to-sport assessment methodologies, and injury risk mitigation strategies.[3] The profile also highlights his participation in healthcare leadership, interdisciplinary clinical practice, and research-oriented physiotherapy education.[4]

Keywords

Health Professions, Physiotherapy, ACL Rehabilitation, Sports Medicine, Musculoskeletal Research, Evidence-Based Practice, Clinical Rehabilitation, Knee Injury Research, Return-to-Sport Testing, Advanced Physiotherapy Practice

Introduction

Contemporary healthcare systems increasingly emphasize interdisciplinary rehabilitation, injury prevention, and evidence-informed physiotherapy interventions. Within this context, clinicians engaged in both practical and academic healthcare activities contribute significantly to the development of patient-centered rehabilitation frameworks. Dominic Richmond’s professional profile illustrates the integration of advanced physiotherapy practice with sports medicine research and musculoskeletal healthcare delivery.[5]

Richmond has worked across clinical, academic, and elite sports environments, including orthopaedic clinics, rehabilitation programs, and research-focused healthcare initiatives. His involvement with Cambridge University Hospitals NHS Foundation Trust and postgraduate studies at the University of Birmingham reflects continued engagement with advanced clinical reasoning, healthcare education, and translational rehabilitation research.[2]

Research Profile

Dominic Richmond’s research profile centers on physiotherapy, sports rehabilitation, and musculoskeletal injury management. His Scopus author profile records publications and citations related to ACL rehabilitation and return-to-sport methodologies.[1] His research interests include knee rehabilitation, strength and conditioning, injury prevention, and evidence-based physiotherapy interventions.

In addition to peer-reviewed publications, Richmond has participated in scientific conferences including the European College of Sport Science and UK Strength and Conditioning Association meetings. These activities demonstrate engagement with international scientific communication and collaborative research dissemination.[6]

  • Advanced Practice Physiotherapist specializing in knee rehabilitation and ACL pathways
  • Research involvement in sports medicine and return-to-sport evaluation
  • Participation in NIHR Health and Care Professional Internship Programme
  • Contributor to musculoskeletal physiotherapy education and clinical supervision

Research Contributions

Richmond has contributed to research examining injury rehabilitation strategies and musculoskeletal performance outcomes. His published and presented work includes investigations into ACL rehabilitation pathways and muscle-tendon mechanics associated with eccentric training interventions.[7]

His research collaborations have explored risk factors associated with sports-related injuries and return-to-sport testing after ACL reconstruction. These studies contribute to ongoing discussions concerning rehabilitation quality, athlete recovery, and evidence-based physiotherapy practice.[8]

  • Research on ACL injury priorities among at-risk female populations
  • Systematic review and meta-analysis related to return-to-sport testing
  • Conference presentations involving muscle-tendon mechanics and eccentric training
  • Clinical audit and healthcare improvement initiatives in musculoskeletal services

Publications

  1. Richmond, D., White, C., & Gomulko, T. Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports, 2026.
  2. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise, 2016.
  3. Research priorities for ACL injuries in at-risk groups – The female population. Published in Knee, 2025.[1]

Research Impact

Richmond’s academic output demonstrates measurable engagement within sports medicine and physiotherapy literature. According to Scopus metrics, his publications have received scholarly citations that reflect emerging influence within musculoskeletal rehabilitation research.[1] His work addressing ACL rehabilitation contributes to contemporary discussions concerning rehabilitation benchmarks, athlete recovery standards, and evidence-informed return-to-sport assessments.

Beyond publication metrics, Richmond’s research impact is reinforced by his participation in healthcare leadership programs, conference presentations, and integration of research findings into clinical rehabilitation pathways. Such contributions support broader healthcare objectives focused on patient outcomes, rehabilitation quality, and multidisciplinary collaboration.[4]

Award Suitability

Dominic Richmond’s professional and academic profile aligns with the objectives commonly associated with the Best Researcher Award within the Global Innovation Technologist Awards framework. His combined contributions to clinical physiotherapy, musculoskeletal rehabilitation research, healthcare education, and interdisciplinary sports medicine demonstrate engagement with both scientific inquiry and applied healthcare innovation.[9]

The integration of evidence-based rehabilitation methods into advanced clinical practice, alongside conference participation and peer-reviewed publications, reflects sustained commitment to healthcare advancement. His role in ACL rehabilitation leadership and musculoskeletal clinical services further supports recognition within professional health professions awards programs.[5]

Conclusion

Dominic Richmond represents an emerging contributor within physiotherapy and sports rehabilitation research. His academic publications, clinical leadership activities, and participation in healthcare-focused research initiatives collectively demonstrate ongoing engagement with musculoskeletal rehabilitation science and evidence-based healthcare practice. Through collaborative research, advanced clinical service delivery, and scholarly dissemination, Richmond contributes to the evolving landscape of health professions and rehabilitation medicine.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Dominic Richmond, Author ID 57189870953. Scopus.
    www.scopus.com/authid/detail.uri?authorId=57189870953
  2. University of Birmingham. (2025). Academic and professional profile associated with advanced physiotherapy studies and healthcare practice.
  3. ORCID. (2026). Dominic Richmond ORCID Profile.
    orcid.org/0009-0001-9270-937X
  4. Cambridge University Hospitals NHS Foundation Trust. (2026). Advanced Practice Physiotherapy and rehabilitation leadership activities.
  5. Richmond, D. (2026). Clinical rehabilitation and ACL management contributions in musculoskeletal healthcare.
  6. European College of Sport Science. (2013). Conference proceedings and research presentation abstracts involving muscle-tendon mechanics.
  7. Kay, A.D., Richmond, D., Talbot, C., Mina, M., Baross, A.W., & Blazevich, A.J. (2016). Stretching of Active Muscle Elicits Chronic Changes in Multiple Strain Risk Factors. Medicine & Science in Sports & Exercise.
  8. Richmond, D., White, C., & Gomulko, T. (2026). Pass Rates of Return to Sport Test Batteries Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports.
    doi.org/10.3390/sports14050211
  9. Global Innovation Technologist Awards. (2026). International recognition framework for innovation and research excellence.
    innovationtechnologist.com

Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Dr. Catherine Frenkel | Medicine and Health Sciences | Research Excellence Award

Levine Cancer Institute | United States

Dr. Catherine Frenkel is a surgeon-scientist specializing in head and neck oncology, surgical innovation, and clinical ethics. Her research integrates oncologic outcomes with ethical frameworks, particularly in areas such as robotic surgery, telesurgery, and decision-making in complex cancer care. She has contributed significantly to enhanced recovery after surgery (ERAS) protocols and multidisciplinary cancer treatment optimization. Her work also explores ethical challenges in transplantation and AI integration in surgical practice. Dr. Catherine Frenkel is actively involved in clinical research as a principal investigator, focusing on improving patient outcomes and healthcare delivery through evidence-based and ethically grounded innovations in surgical oncology.

                            Citation Metrics (Scopus)

300

250

200

150

100

50

0

 

Citations
197
Documents
20
h-index
7

Citations

Documents

h-index

View Scopus Profile  View Google Scholar Profile  View ORCID Profile

Featured Publications

Bing Hu | Medicine | Best Researcher Award

Published on by Innovation Technologist

Dr. Bing Hu | Medicine | Best Researcher Award

Hearing Research at Shenzhen University, China

Dr. Bing Hu is a senior clinical otolaryngologist and postdoctoral fellow in Clinical Medicine at Sun Yat-sen University. With over 16 years of experience in the diagnosis, treatment, and surgical management of ENT (Ear, Nose, and Throat) diseases, Dr. Hu brings deep clinical knowledge and research expertise. He has been jointly trained by Xiangya Medical College and Case Western Reserve University (USA), and has held a visiting scholar position at the renowned Cleveland Clinic. His clinical proficiency, combined with an active role in medical research, has resulted in numerous national-level project participations and over 10 peer-reviewed publications.

Publication Profile 

Scopus

Orcid

Educational Background 🎓

  • Doctor of Medicine (M.D.)
    Joint program by Case Western Reserve University (USA) & Xiangya Medical College (China)

  • Ph.D. in Clinical Medicine
    Sun Yat-sen University, China

  • Postdoctoral Fellowship in Clinical Medicine
    Sun Yat-sen University

  • Clinical Training

    • Eye, Ear, Nose, and Throat Hospital, Fudan University

    • First Affiliated Hospital, Sun Yat-sen University

Professional Experience 💼

  • Postdoctoral Fellow
    Department of Clinical Medicine, Sun Yat-sen University

  • ENT Specialist and Surgeon
    Department of Otolaryngology – Head and Neck Surgery, Shenzhen Secondary Hospital & First Affiliated Hospital of Shenzhen University

  • Visiting Scholar
    Cleveland Clinic, USA

  • Clinical Doctor (16 years experience)

    • Expertise in diagnosis and surgical management of ENT diseases

    • Practiced at multiple tier-one hospitals in China

Research Interests 🔬

  • Otolaryngologic Diseases (ENT)

  • Minimally Invasive Endoscopic Surgery

  • Inflammatory and Infectious Diseases of the ENT System

  • Pediatric ENT Conditions (Adenoid Hypertrophy, Tonsillitis)

  • Surgical Management of Sinusitis, Rhinitis, Epistaxis

  • Clinical Outcomes and Patient-Centered Treatment Optimization

Awards and Honors🏆✨

  • National Scholarship for Scholarly Exchange
    Awarded for outstanding performance in international medical training and research

  • Visiting Scholar Recognition
    Cleveland Clinic – Recognized for advanced clinical research contributions

  • Contributor and Investigator in Multiple Funded Projects
    At national, provincial, and municipal levels

Conclusion🌟

Dr. Bing Hu exemplifies the integration of clinical excellence with academic rigor. His dual training in China and the United States, along with his extensive surgical expertise and research involvement, position him as a leading figure in the field of otolaryngology. His continued work at the intersection of patient care and innovation ensures his lasting impact on ENT practice and education in China and beyond.

Publications 📚

  • 📌 3D UNet-based Abdominal Organ Automatic Segmentation Model using Image Denoising and Point Cloud Fusion
    📰 Alexandria Engineering Journal | 📅 2025
    👨‍💻 Authors: Xue J., Hu B.
    🔓 Open Access

  • 🧬 Toe1 Promotes Proliferation and Differentiation of Neural Progenitor Cells
    📰 Heliyon | 📅 2024
    👨‍💻 Authors: Deng T., Wu X., Wang Y., Fan X., Hu B.
    🔁 Cited: 1

  • 🧏‍♂️ BRCA1 Promotes Repair of DNA Damage in Cochlear Hair Cells and Prevents Hearing Loss
    📰 The Journal of Neuroscience | 📅 2024-09-03
    🔗 DOI: 10.1523/jneurosci.0132-24.2024
    👨‍💻 Authors: Jiang W., Wang G., Bai F., Hu B., Xu Y., et al.

  • 🎧 Advancements in Prevention and Intervention of Sensorineural Hearing Loss
    📰 Therapeutic Advances in Chronic Disease | 📅 2022-06-27
    🔗 DOI: 10.1177/20406223221104987
    👨‍💻 Authors: Hong, Hu B., Jiang G.
    📂 PMC: PMC9243368

  • 🌿 Novel Application of Eupatilin for Effectively Attenuating Cisplatin-Induced Auditory Hair Cell Death via Mitochondrial Apoptosis Pathway
    📰 Oxidative Medicine and Cellular Longevity | 📅 2022-01-17
    🔗 DOI: 10.1155/2022/1090034
    📂 PMC: PMC8786471

  • 🩺 Effectiveness of Salvage Intratympanic Dexamethasone Treatment for Refractory Sudden Sensorineural Hearing Loss Classified by Audiogram Patterns
    📰 Acta Oto-Laryngologica | 📅 2021-02-27
    🔗 DOI: 10.1080/00016489.2021.1889029

  • 💊 Autophagy Impairment as a Key Feature for Acetaminophen-Induced Ototoxicity
    📰 Cell Death & Disease | 📅 2021-01-04
    🔗 DOI: 10.1038/s41419-020-03328-6
    📂 PMC: PMC7791066

  • 🔬 Liproxstatin-1 Protects Hair Cell-Like HEI-OC1 Cells and Cochlear Hair Cells against Neomycin Ototoxicity
    📰 Oxidative Medicine and Cellular Longevity | 📅 2020-12-01
    🔗 DOI: 10.1155/2020/1782659
    📂 PMC: PMC7725559

  • ⚗️ Ferrostatin-1 Protects Auditory Hair Cells from Cisplatin-Induced Ototoxicity In Vitro and In Vivo
    📰 Biochemical and Biophysical Research Communications | 📅 2020-10-24
    🔗 DOI: 10.1016/j.bbrc.2020.10.019

  • 🌱 Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma
    📰 Journal of the Association for Research in Otolaryngology (JARO) | 📅 2018-09-05
    🔗 DOI: 10.1007/s10162-018-00690-3
    📂 PMC: PMC6249158

  • 🧬 Atoh1: Landscape for Inner Ear Cell Regeneration
    📰 Current Gene Therapy | 📅 2014
    🔗 DOI: 10.2174/1566523214666140310143407